|
Pharmacokinetic profile |
|||||
| Study medication |
Water Volume |
Dose pre-meal |
AUC0–4 pg/ml × hrs |
Cmax pg/ml |
Tmax minutes |
|
|
|||||
| SMC021 |
50 ml |
10 min |
52.2 (46.0–59.4) |
103 (89–118) |
15 (10–23) |
| SMC021 |
50 ml |
30 min |
68.9 (60.2–78.9) |
125 (110–144) |
15 (15–30) |
| SMC021 |
50 ml |
60 min |
74.4 (64.0–86.5) |
145 (125–168) |
15 (15–30) |
|
|
|||||
| SMC021 |
200 ml |
10 min |
27.4 (25.2–29.7) |
52 (45–59) |
15 (10–15) |
| SMC021 |
200 ml |
30 min |
32.9 (29.1–37.3) |
56 (48–67) |
15 (15–30) |
| SMC021 |
200 ml |
60 min |
33.6 (29.5–38.1) |
49 (42–58) |
15 (12.5–30) |
|
|
|||||
| Miacalcic |
N/A |
60 min |
16.4 (13.8–19.4) |
11.4 (8.3–15.5) |
15 (10–15) |
|
AUC0–4 and Cmax is given as geometric mean (mean ± 1 sem), and Tmax as median (25–75 percentile) | |||||
Karsdal et al. BMC Clinical Pharmacology 2008 8:5 doi:10.1186/1472-6904-8-5 |
|||||